Careers  |  Sign In  |  Register

Latest in Hospitalist

Reuters Health • The Doctor's Channel Daily Newscast

Tolvaptan Corrects Hyponatremia in Cancer Patients

NEW YORK (Reuters Health) – In hospitalized cancer patients, the common problem of hyponatremia can be corrected by administration of the orally active V2 receptor antagonist, tolvaptan. The finding comes from a relatively small double-blind placebo-controlled trial.  “The correction in the tolvaptan...
Medical errors may contribute to illness and even death for hospitalized patients. Many of these errors come from miscommunication during the handoff, that's when patient information is communicated from one care provider finishing their shift, to another beginning a shift. A new study examined ways to...
The New York Times reports that new research published in NEJM has shown that a high-tech cardiac implant may increase the risk of blood clots. The results found that the incidence of blood clots in patients who had the HeartMate II, manufactured by Thoratec Corp., was nearly four times that of patients...